WO2005063219A3 - Ibuprofen-containing soft gelatin capsules - Google Patents

Ibuprofen-containing soft gelatin capsules Download PDF

Info

Publication number
WO2005063219A3
WO2005063219A3 PCT/IB2004/004185 IB2004004185W WO2005063219A3 WO 2005063219 A3 WO2005063219 A3 WO 2005063219A3 IB 2004004185 W IB2004004185 W IB 2004004185W WO 2005063219 A3 WO2005063219 A3 WO 2005063219A3
Authority
WO
WIPO (PCT)
Prior art keywords
ibuprofen
gelatin capsules
soft gelatin
containing soft
relates
Prior art date
Application number
PCT/IB2004/004185
Other languages
French (fr)
Other versions
WO2005063219A2 (en
Inventor
Vivek Mahendrakumar Dubey
Visingiri Venkat Ram Mohan Rao
Abhijit Mukund Deshmukh
Sanjeev Kumar Sethi
Original Assignee
Ranbaxy Lab Ltd
Vivek Mahendrakumar Dubey
Visingiri Venkat Ram Mohan Rao
Abhijit Mukund Deshmukh
Sanjeev Kumar Sethi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd, Vivek Mahendrakumar Dubey, Visingiri Venkat Ram Mohan Rao, Abhijit Mukund Deshmukh, Sanjeev Kumar Sethi filed Critical Ranbaxy Lab Ltd
Publication of WO2005063219A2 publication Critical patent/WO2005063219A2/en
Publication of WO2005063219A3 publication Critical patent/WO2005063219A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to ibuprofen-containing soft gelatin capsules, pharmaceutical compositions of a substantially clear ibuprofen solution, and process for their manufacture. It also relates to pharmaceutical compositions of substantially clear solutions containing ibuprofen and pseudoephedrine and use of such compositions for treatment of common cold and flu-like symptoms.
PCT/IB2004/004185 2003-12-23 2004-12-17 Ibuprofen-containing soft gelatin capsules WO2005063219A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN1606/DEL/2003 2003-12-23
IN1606DE2003 2003-12-23
IN1398DE2004 2004-07-28
IN1398/DEL/2004 2004-07-28

Publications (2)

Publication Number Publication Date
WO2005063219A2 WO2005063219A2 (en) 2005-07-14
WO2005063219A3 true WO2005063219A3 (en) 2005-08-11

Family

ID=34740780

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2004/004185 WO2005063219A2 (en) 2003-12-23 2004-12-17 Ibuprofen-containing soft gelatin capsules

Country Status (1)

Country Link
WO (1) WO2005063219A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI313598B (en) 2002-12-18 2009-08-21 Wyeth Corp Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines
US20050192355A1 (en) * 2004-02-17 2005-09-01 Wyeth Compositions of non-steroidal anti-inflammatory drugs and decongestants or anti-histamines
WO2009089134A1 (en) 2008-01-04 2009-07-16 Src, Inc. Methods for measuring a patint response upon administration of a drug and compositions thereof
WO2010056216A1 (en) * 2008-11-11 2010-05-20 Berko Ilac Ve Kimya San.A.S. Pharmaceutical composition comprising ibuprofen, pseudoephedrine and chlorpheniramine
CA2919892C (en) 2013-08-12 2019-06-18 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9707184B2 (en) 2014-07-17 2017-07-18 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
EP3209282A4 (en) 2014-10-20 2018-05-23 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
CN105982876A (en) * 2015-01-27 2016-10-05 深圳市佳泰药业股份有限公司 Econazole nitrate vagina soft capsule and preparation method thereof
GB2595300B (en) * 2020-05-21 2024-03-27 Reckitt Benckiser Health Ltd Novel Formulation
CA3124579A1 (en) 2020-07-15 2022-01-15 Schabar Research Associates Llc Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity of heartburn and/or the risk of heartburn
AU2021310264A1 (en) 2020-07-15 2023-02-09 Schabar Research Associates Llc Unit oral dose compositions composed of ibuprofen and famotidine for the treatment of acute pain and the reduction of the severity and/or risk of heartburn

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5376688A (en) * 1992-12-18 1994-12-27 R. P. Scherer Corporation Enhanced solubility pharmaceutical solutions
US6387400B1 (en) * 2000-08-29 2002-05-14 R.P. Scherer Technologies, Inc. Process for preparing pharmaceutical compositions for use with soft gelatin formulations
WO2002069936A2 (en) * 2001-03-02 2002-09-12 Dr. Reddy's Laboratories Ltd. Pharmaceutical composition of ibuprofen

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5376688A (en) * 1992-12-18 1994-12-27 R. P. Scherer Corporation Enhanced solubility pharmaceutical solutions
US6387400B1 (en) * 2000-08-29 2002-05-14 R.P. Scherer Technologies, Inc. Process for preparing pharmaceutical compositions for use with soft gelatin formulations
WO2002069936A2 (en) * 2001-03-02 2002-09-12 Dr. Reddy's Laboratories Ltd. Pharmaceutical composition of ibuprofen

Also Published As

Publication number Publication date
WO2005063219A2 (en) 2005-07-14

Similar Documents

Publication Publication Date Title
WO2004055006A8 (en) Novel compounds having selective inhibiting effect at gsk3
WO2005063219A3 (en) Ibuprofen-containing soft gelatin capsules
ZA200203867B (en) alpha-Amino acids compounds, a process for their preparation and pharmaceutical compositions containing them.
WO2005070390A3 (en) Mitratapide oral solution
MXPA03007712A (en) Pharmaceutical salts.
NO324227B1 (en) Cyclopropyl-fused pyrrolidine-based compounds, pharmaceutical compositions and combinations containing them as well as the use thereof for the manufacture of medicaments for the treatment of diseases
ZA200202525B (en) α-amino acid sulphonyl compounds, a process for their preparation and pharmaceutical compositions containing them.
WO2004074232A8 (en) 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases
TW200505505A (en) Process for modifying drug crystal formation
WO2005046727A3 (en) Ibuprofen-containing soft gelatin capsules
WO2003087049A3 (en) Pharmaceutical combinations containing heterocyclic compounds and a novel anticholinergic agent
AU2002312897A1 (en) Drugs for the treatment of the alzheimer disease
WO2003087062A3 (en) 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation
AU2002348829A1 (en) Novel compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
WO2004081199A3 (en) Novel compositions and methods for the treatment of immune related disease
WO2003059323A3 (en) Stable salts of o-acetylsalicylic acid containing basic amino acids ii
HK1063606A1 (en) Medicament containing an effector of the glutathione metabolism together with alpha-lopic acid for use in kidney replacement therapy.
MXPA03008211A (en) Predispersions, process for their preparation, compositions therefor, process for the preparation of such compositions.
WO2004010974A3 (en) Gelatin capsule exhibiting reduced cross-linking
PL377706A1 (en) Pharmaceutical composition of alendronic acid, salts or esters thereof, and a process for its preparation
AU2002238673A1 (en) Human adrenomedullin-specific antibody, pharmaceutical composition containing same, therapeutic uses thereof
WO2002067894A3 (en) Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors
AU2001244999A1 (en) Naphthamide neurokinin antagonists for use as medicaments
EA200801894A1 (en) NEW ENANTIOMETRIC PURE β-AGONISTS, METHOD FOR THEIR RECOVERY AND THEIR APPLICATION AS MEDICINAL PRODUCTS
ITMI20011718A0 (en) PROCESS FOR THE PREPARATION OF THE SODIUM SALT OF ACID-6(D-(-)-ALPHA-(4-ETHYL-2,3-DIOXO-1-PIPERAZINOCARBONYLAMINO)PHENYLACETAMIDE)PENICILL

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Ref document number: DE

WWE Wipo information: entry into national phase

Ref document number: 3785/DELNP/2006

Country of ref document: IN

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
122 Ep: pct application non-entry in european phase